• Federal Vaccine Court Rules Against Autism Families  (PR Newswire)
   
• Special Masters Protect Vaccine Program and Deny Justice to Vaccine-Injured Children  (PR Newswire)
   
• FDA Announces New Boxed Warning on Plavix  (PR Newswire)
   
• What Real Health Care Reform Must Address  (PR Newswire)
   
• Will Patient Privacy Be Sold for Stimulus Money?  (PR Newswire)
   
• Prominent Farmington Hills Plastic Surgeon Warns of Complications of Silicone Injections for Buttocks Augmentation  (PR Newswire)
   
• AVMA, Veterinary Foundation Tackle Veterinary Shortage With New Incentive Program  (PR Newswire)
   
• Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illn (PR Newswire)
   
• More Lower Extremity, Orthopaedic-Related Injuries Occur When Playing on FieldTurf  (PR Newswire)
   
• Green Tea Extract May Delay or Prevent Alzheimer's  (PR Newswire)
   
• FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)  (PR Newswire)
   
• AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma  (PR Newswire)
   
• IBM Executive Dr. Martin Sepulveda Wins Prestigious National Business Group on Health Award  (PR Newswire)
   
• Health Occupations Students of America, Inc. and the U.S. Army Sign Memorandum of Understanding in Support of Improving Career Options for Nation's Students  (PR Newswire)
   
• Haven Behavioral War Heroes Hospital to Offer Comprehensive Psychiatric Treatment for Military Service Members  (PR Newswire)
   
• Eisai Enters Licensing Agreement with Johns Hopkins Brain Science Institute  (PR Newswire)
   
• TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints  (PR Newswire)
   
• Orexigen(R) Therapeutics and Patheon Announce Exclusive Manufacturing Agreement for Contrave(R)  (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

 

• Today is World Kidney Day: Dialysis Patient Citizens Call for Greater Education and Awareness in 2010  (PR Newswire)
   
• CVS Caremark Annual Employer Survey Finds Majority of Employers Rate Managing Costs as Top Priority in 2010  (PR Newswire)
   
• Legacy(SM) Case for Tobacco Funds to be Heard by Ohio Supreme Court  (PR Newswire)
   
• Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation  (PR Newswire)
   
• Diabetes Experts Call for Early, Integrated Treatment Approach to Help Prevent Complications and Improve Patient Outcomes  (PR Newswire)
   
• Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases  (PR Newswire)
   
• Newly-Published Study Reinforces Role of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) as an Add-on Treatment that Significantly Reduces Partial-onset Seizures in Adults with Epilepsy  (PR Newswire)
   
• Access Pharmaceuticals Reports Significant Oral Bioavailability of Cobalamin(TM) Oral Insulin in Additional Studies  (PR Newswire)
   
• PSA Test Reduces Prostate Cancer Deaths by 40%  (PR Newswire)
   
• Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage  (PR Newswire)
   
• FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis  (PR Newswire)
   
• FDA Approves Boston Scientific's Express(R) LD Iliac Stent System  (PR Newswire)
   
• Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer  (PR Newswire)
   
• Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications  (PR Newswire)
   
• SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies  (PR Newswire)
   
• Effort Aims to Spike Breast Cancer With New Approach  (PR Newswire)
   
• Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan  (PR Newswire)
   
• Sigma-Aldrich(R) Licenses RAFT Polymerization Technology From CSIRO(R)  (PR Newswire)
   
• Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.  (PR Newswire)
   
• Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala  (PR Newswire)
   
• bioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool  (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• Pediatric Sports Injuries: The Silent Epidemic  (PR Newswire)
   
• Insurance Regulation Expert Calls for Freeze of Health Rates Until 'Prior Approval' Regulation Is Adopted  (PR Newswire)
   
• MARC Coalition Supports Medicare Secondary Payer Enhancement Act (MSPEA)/H.R. 4796  (PR Newswire)
   
• European Countries to Agree New Targets to Fight Environmental Threats to Health  (PR Newswire)
   
• Pew Statement on Congressional Hearing Regarding FDA Drug Safety Reforms  (PR Newswire)
   
• Pulmonary Fibrosis Patient Organizations Applaud Efforts of Patients, Families at FDA Hearing  (PR Newswire)
   
• RetireSafe Urges All Seniors to Call on Congress to Save Physician Hospitals' Quality Care for Medicare Patients  (PR Newswire)
   
• Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors  (PR Newswire)
   
• Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says  (PR Newswire)
   
• Study Predicts Half of Physician Continuing Education Will Be Online by 2016  (PR Newswire)
   
• Nurse Practitioners to Patients: Can We Talk?  (PR Newswire)
   
• Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs May Affect Quality and Structural Integrity of Bone  (PR Newswire)
   
• Breakthroughs in Treatment of Spine and Back Conditions  (PR Newswire)
   
• Research Findings Expected to Ease Treatment of Low Neutrophil Counts in Cancer Patients  (PR Newswire)
   
• Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B  (PR Newswire)
   
• Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia  (PR Newswire)
   
• Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens  (PR Newswire)
   
• FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers  (PR Newswire)
   
• Watson Announces Actos(R) Patent Challenge Settlement  (PR Newswire)
   
• Smith & Nephew Announces Next Steps in Patent Infringement Litigation  (PR Newswire)
   
• St. Jude Ranked the Most Trusted Charity in the U.S. in New Harris Interactive Survey  (PR Newswire)
   
• DC Dermatologist Dr. Susan T. Elliott Selected 'Best Doctor' by Washingtonian Magazine  (PR Newswire)
   
• Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease  (PR Newswire)
   
• CardioGenics Announces Further Update Regarding Status of Merck Agreement  (PR Newswire)
   
• China Medicine Corporation Applies to List on NASDAQ Global Market  (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• CDC Study Finds U.S. Herpes Rates Remain High  (PR Newswire)
   
• New Report Says African-Americans and Hispanics More Likely to Have Alzheimer's Disease And Dementia Than Whites  (PR Newswire)
   
• K-State Study Finds Abundance of Food Stores, Not Lack of Them, Puts Low-Income Women In Small Cities at Higher Risk of Obesity  (PR Newswire)
   
• Starting Treatment Early Doubles Chance of Success for People with Diabetes  (PR Newswire)
   
• New Survey Indicates More Than 17 Million Cosmetic Procedures Performed Last Year in U.S.  (PR Newswire)
   
• Ambiguous Language Could Drive Up Rather Than Curtail Health Care Costs  (PR Newswire)
   
• Only One State Passed Legislation in 2009 Requiring Insurers to Cover Costs of Colon Cancer Screening  (PR Newswire)
   
• A Year Since Obama's Lifting of Ban on Stem Cell Funding, Boston Team Ready to Distribute Lines Worldwide But Obstacles Remain. New Website to End Public Confusion and Push Science Forward  (PR Newswire)
   
• Cord Blood America's New Medical Director Says Parkinson's, Diabetes Among Diseases to be Treated With Umbilical Cord Blood Stem Cells  (PR Newswire)
   
• Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus  (PR Newswire)
   
• Bill & Melinda Gates, Asian Parliamentary Group, Win 2010 United Nations Population Award  (PR Newswire)
   
• Jury Verdict Against Novartis Pharmaceuticals For Retaliating Against Drug Sales Rep Who Took Maternity Leave  (PR Newswire)
   
• Chicago Hospital to Pay More Than $1.5 Million to Resolve Medicare False Claims Act Allegations  (PR Newswire)
   
• Pharmacists File Class Action Against Cardinal Health, Medicine Shoppe, and Medicap Pharmacies  (PR Newswire)
   
• Patients With Irritable Bowel Syndrome Not More Likely to Develop Polyps or Colon Cancer, U-M Study Says  (PR Newswire)
   
• Eat Strawberries to Feel Good and Win!  (PR Newswire)
   
• New Evidence Further Validates Ketone Body Therapy as an Effective Approach in Managing Alzheimer's Disease  (PR Newswire)
   
• AdMeTech Hails New Research That Shows Promise of MRI to Discriminate Aggressive Prostate Cancer From Dormant Disease  (PR Newswire)
   
• FDA Advisory Committee Recommends Approval of InterMune's Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis  (PR Newswire)
   
• Military Medical Experts to Offer Update on Push For Early Diagnosis of Combat Brain Injuries  (PR Newswire)
   
• Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech  (PR Newswire)
   
• Massachusetts Institute of Technology (MIT) to Launch New Brain Research Effort with Acquisition of Elekta MEG Technology  (PR Newswire)
   
• 2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia  (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

 

• Listen to Us -- Not the Insurance Companies': Thousands Head to D.C. to Protest Big Insurance  (PR Newswire)
   
• Survey Reveals Health Insurance and Access to Care Not So Closely Linked  (PR Newswire)
   
• Idaho Senate Set to Bring Home Divisiveness of Health Care Fight  (PR Newswire)
   
• Poll Reveals Sleep Differences Among Ethnic Groups  (PR Newswire)
   
• Vilcek Foundation Names Recipients of 2010 Annual Prizes Celebrating Immigrant Achievement in Biomedical Science and Arts  (PR Newswire)
   
• SBS to Honor Three Researchers for Outstanding Contributions to Advancing the Science of Drug Discovery  (PR Newswire)
   
• Beverage Industry Delivers On Commitment to Remove Regular Soft Drinks In Schools, Driving 88% Decline In Calories  (PR Newswire)
   
• Chicago AIDS Advocates Launch Female Condom Campaign  (PR Newswire)
   
• Outreach Program to Increase Awareness of New Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment  (PR Newswire)
   
• New Justice Department Outreach Effort to Victims of Radiation Exposure Announced  (PR Newswire)
   
• Gene Site Found for a Children's Food Allergy  (PR Newswire)
   
• New Article Reveals Trend Toward Greater Use of Human Menopausal Gonadotropin in In Vitro Fertilization  (PR Newswire)
   
• Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer  (PR Newswire)
   
• Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors  (PR Newswire)
   
• ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)  (PR Newswire)
   
• FDA Approves NerPharMa to Manufacture Cell Therapeutics' Drug Pixantrone  (PR Newswire)
   
• Women for Positive Action: an International Partnership Dedicated to Enhancing the Lives of Women Living with HIV  (PR Newswire)
   
• Lilly to Acquire European Rights to Pfizer Animal Health Assets  (PR Newswire)
   
• Gentiva(R) Health Services Acquires Mississippi Hospice Provider  (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs